<DOC>
	<DOCNO>NCT00096421</DOCNO>
	<brief_summary>The purpose study evaluate impact tight control serum glucose level intensive insulin treatment patient hospitalize intensive care unit medical surgical patient .</brief_summary>
	<brief_title>Tight Glycemic Control Critical Care Patients</brief_title>
	<detailed_description>Reduction morbidity-mortality critical care patient tight glycemic control proven surgical patient . Study Hypothesis : In critical care patient , medical surgical , glucose serum level 80 - 110 mg/dL mean low mortality patient glucose level 110 mg/dL .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>15 year age old , Probability stay critical care 48 hour , Agreement inform consent . Pregnancy , Participating trial , Diabetic ketoacidosis diabetic hyperosmolar state , Moribund Donotresuscitate order , Reentry critical care unit patient .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Critical illness</keyword>
	<keyword>Critical care</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Intensive care</keyword>
	<keyword>Intensive Care Units</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Intensive insulin therapy</keyword>
	<keyword>Conventional insulin therapy</keyword>
</DOC>